A group of investors, including Hanwha Impact, CPP Investments, Rivas Capital, NGS Super, State of Michigan Retirement System, Flagship Pioneering and RCM Private Markets led a $103m funding in Inari Agriculture, a biotechnology research company. “This fundraise comes at an exciting time for the company, helping to further advance our cutting-edge technologies and enter the commercialization phase – bringing our breakthrough products into the hands of seed customers,” Ponsi Trivisvavet, Inari CEO.